enzastaurin has been researched along with go 6976 in 1 studies
| Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (go 6976) | Trials (go 6976) | Recent Studies (post-2010) (go 6976) |
|---|---|---|---|---|---|
| 188 | 52 | 99 | 504 | 1 | 133 |
| Protein | Taxonomy | enzastaurin (IC50) | go 6976 (IC50) |
|---|---|---|---|
| Protein kinase C gamma type | Homo sapiens (human) | 0.002 | |
| Protein kinase C beta type | Homo sapiens (human) | 0.0041 | |
| Protein kinase C alpha type | Homo sapiens (human) | 0.0027 | |
| Protein kinase C delta type | Homo sapiens (human) | 0.446 | |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | 0.0445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armann, J; Baumann, P; Grün, G; Mandl-Weber, S; Oduncu, F; Schmidmaier, R | 1 |
1 other study(ies) available for enzastaurin and go 6976
| Article | Year |
|---|---|
Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs.
Topics: Antineoplastic Agents; Apoptosis; Bone Marrow; Carbazoles; Cell Proliferation; Cells, Cultured; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Indoles; Melphalan; Multiple Myeloma; Mutagens; Protein Kinase C; Protein Kinase Inhibitors | 2008 |